Allurion Technologies Inc.

NYSE:ALUR Stock Report

Market Cap: US$13.9m

Allurion Technologies Management

Management criteria checks 0/4

Allurion Technologies' CEO is Shantanu Gaur, appointed in Jan 2009, has a tenure of 16.33 years. total yearly compensation is $2.83M, comprised of 21.9% salary and 78.1% bonuses, including company stock and options. directly owns 1.17% of the company’s shares, worth $163.17K. The average tenure of the management team and the board of directors is 1.3 years and 2.5 years respectively.

Key information

Shantanu Gaur

Chief executive officer

US$2.8m

Total compensation

CEO salary percentage21.9%
CEO tenure16.3yrs
CEO ownership1.2%
Management average tenure1.3yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

author-image

Low-dose GLP-1 Combo And FDA Approval Will Expand Obesity Care

Apr 20 The combination therapy approach and clinical advancements are set to drive increased revenue and expand market share in obesity and related treatments.

Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper

Nov 15
Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper

CEO Compensation Analysis

How has Shantanu Gaur's remuneration changed compared to Allurion Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$3mUS$620k

-US$26m

Sep 30 2024n/an/a

-US$25m

Jun 30 2024n/an/a

-US$38m

Mar 31 2024n/an/a

-US$58m

Dec 31 2023US$661kUS$355k

-US$82m

Sep 30 2023n/an/a

-US$76m

Jun 30 2023n/an/a

-US$69m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$3mUS$295k

-US$41m

Compensation vs Market: Shantanu's total compensation ($USD2.83M) is above average for companies of similar size in the US market ($USD677.79K).

Compensation vs Earnings: Shantanu's compensation has increased whilst the company is unprofitable.

CEO

Shantanu Gaur (37 yo)

16.3yrs

Tenure

US$2,829,734

Compensation

Dr. Shantanu K. Gaur, M.D. co-founded Allurion Technologies, Inc. in 2009 and has been its Chief Executive Officer since January 1, 2018 and also serves as its President and had been its Secretary. Dr. Gau...

Leadership Team

NamePositionTenureCompensationOwnership
Shantanu Gaur
Co-Founder16.3yrsUS$2.83m1.17%
$ 163.2k
Ojas Buch
Chief Operating Officerless than a yearUS$1.16mno data
Brendan Gibbons
Chief Legal Officer & Corporate Secretary1.3yrsUS$1.13m0%
$ 0
Samuel Levy
Co-Founder16.3yrsno datano data
Ram Chuttani
MD, Chief Medical Officer & Founding Partnerno datano datano data
Matt Wright
Vice President of People1.2yrsno datano data
Adrian Wild
Senior Vice President of International Commercialless than a yearno datano data

1.3yrs

Average Tenure

48yo

Average Age

Experienced Management: ALUR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Shantanu Gaur
Co-Founder15.7yrsUS$2.83m1.17%
$ 163.2k
Robert S. Langer
Chairman of Scientific Advisory Board2.5yrsno datano data
Michael Davin
Independent Director7.6yrsUS$72.50k0.044%
$ 6.1k
S. Ishrak
Chairman & Lead Independent Director1.8yrsUS$105.00k0.48%
$ 66.2k
Larson Hudson
Independent Director1.8yrsUS$62.50k0%
$ 0
Harold Solomon
Medical Advisorno datano datano data
Krishna Gupta
Independent Director8.3yrsUS$95.00k0.63%
$ 87.5k
John Morton
Medical Advisorno datano datano data
Milena Alberti-Perez
Independent Director1.2yrsUS$248.23k0%
$ 0
Bruce Schirmer
Medical Advisorno datano datano data
Jordan Busch
Medical Advisorno datano datano data
E.M.H. Mathus-Vliegen
Medical Advisorno datano datano data

2.5yrs

Average Tenure

54yo

Average Age

Experienced Board: ALUR's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/02 12:54
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Allurion Technologies Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keay NakaeChardan Capital Markets, LLC
Matthew TaylorJefferies LLC
Michael ToomeyJefferies LLC